Craft

Elekta

Stock Price

KR66.7

2024-10-29

Market Capitalization

KR25.5 B

2024-10-29

Revenue

KR18.1 B

FY, 2024

Elekta Summary

Company Summary

Overview
Elekta is a medical device company that manufactures radiotherapy solutions for cancer care and brain disorders. It offers solutions in both radiotherapy treatment and oncology informatics systems for oncology clinics.
Type
Public
Status
Active
Founded
1972
HQ
Stockholm, SE | view all locations
Website
http://elekta.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Laurent Leksell

    Laurent Leksell, Board Chairman and Chairman of the Compensation & Sustainability Committee

  • Gustaf Salford

    Gustaf Salford, President and CEO

  • Steve Wort
  • Karin Svenske

    Karin Svenske, Executive Vice President, Human Resources

Operating MetricsView all

Order Intake

kr18B

FY, 2022

Engineers

650

FY, 2022

Patents

1.8K

FY, 2022

LocationsView all

25 locations detected

  • Stockholm, Stockholms län HQ

    Sweden

    Kungstensgatan 18, Box 7593

  • Atlanta, GA

    United States

    400 Perimeter Center Terrace #50

  • North Sydney, NSW

    Australia

    Suite 10.2, Level 10/146 Arthur St

  • Innsbruck, Tirol

    Austria

    Klostergasse 4

  • Zaventem, Vlaams Gewest

    Belgium

    Belgicastraat 11

  • São Paulo, SP

    Brazil

    Av. Brg. Faria Lima, 1355 - 20 andar - Jardim Paulistano

and 19 others

Elekta Financials

Summary Financials

Revenue (Q3, 2025)
kr4.7B
Gross profit (Q3, 2025)
kr2.1B
Net income (Q3, 2025)
kr336.0M
Cash (Q3, 2025)
kr3.6B
EBIT (Q3, 2025)
kr511.0M
Enterprise value
$30.8B

Footer menu